Jerusalem, Israel, June 4, 2010 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced positive results from a study assessing a new lower-volume injection of Copaxone® (glatiramer ...
Copaxone is a prescription drug used to treat different types of multiple sclerosis (MS) in adults. It can cause side effects that range from mild to serious, including injection site reactions, ...
First Generic and clinically validated product for Multiple Sclerosis in Europe Provides an affordable high quality alternative to MS patients, complemented by a range of support services including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results